Citations

Clear

2236 citation(s) found for "Ju, Angela".

Web-Based Amblyopia Decision Support Tool
Summers, Allison I. , Hatch, S.W., Wiecek, Emily , Hribar, Michelle R. , Robinson, Julianne L., Chen, Angela M., Kulp, Marjean T., Chen, Debora M. Lee, Repka, Michael X., Roberts, Tawna L. , Wallace, David K. , Vricella, Marilyn, Chang, Steven, Stutz, Kathleen M., Beaulieu, Wesley T., Kraker, Raymond T., Cotter, Susan A., Holmes, Jonathan M., Weise, Katherine K., Pineles, Stacy L., (PEDIG), Pediatric Eye Disease Investigator Group, Hatt, Sarah R. , Chen, Angela M. , Kulp, Marjean Taylor , Repka, Michael X. , Wang, Jingyun, Beaulieu, Wesley T , Kraker, Raymond T. , Cotter, Susan A. , Holmes, Jonathan M.

Mayo Clinic

JAMA Ophthalmology | May 7, 2026 | Volume: 144 | Issue: 6 | Pages: 545

10.1001/jamaophthalmol.2026.1095 | PMID 42096234 Get It

Importance Amblyopia is the leading cause of monocular decreased best-corrected vision in children. Early detection and intervention are key for optimal treatment outcomes; however, limited access to pediatric eye specialists may hinder timely care and affect visual outcomes. Given the shortage of specialty-trained eye care professionals in the US, there is need to support comprehensive eye care professionals who are willing to examine and treat children with amblyopia. Objective A panel from the Pediatric Eye Disease Investigator Group synthesized relevant literature and incorporated consensus opinion where direct evidence was lacking to create the Amblyopia Navigator Decision-Support Instrument, a free, web-based amblyopia decision support tool for eye care professionals. Evidence Review The decisions related to optimal diagnostic measures, pass/refer criteria, and management recommendations were informed by 147 publications. In areas where direct evidence was lacking, guidance was supplemented with clinical trial protocols or existing professional guidelines. When data were conflicting or unavailable, recommendations were established through committee consensus. A single reviewer independently performed standardized (though not systematic) literature reviews to avoid missing pertinent recent publications. Findings Presented are the process used, supporting evidence, and recommendations for testing methods, refractive correction, amblyopia treatment options, treatment adjustments, and monitoring schedules. Conclusions and Relevance Because amblyopia is common and typically responds well to treatment, decision support tools that optimize its management could increase access to pediatric eye care by facilitating earlier detection, enabling broader participation of primary eye care professionals, and ultimately improving visual outcomes. Through this work and the development of the forthcoming free, web-based application version, Amblyopia Navigator Decision-Support Instrument, the Pediatric Eye Disease Investigator Group has created decision support tools designed to assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia.
PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4 + lymphocytes
Hastie, Elizabeth , Srivasta, Megha, Cachay, Edward R., Burke, Leah, Gianella, Sara, Rawlings, Stephen, Sykes, Craig, Blumenthal, Jill, Cottrell, Mackenzie L. , Burke, Leah , Gianella, Sara , Rawlings, Stephen, Stanczyk, Frank Z. , Sykes, Craig, Kashuba, Angela D. M. , Blumenthal, Jill S. , Cottrell, Mackenzie Leigh

Mayo Clinic

British Journal of Clinical Pharmacology | May 7, 2026 | Volume: 92 | Issue: 8 | Pages: 2949-2959

10.1002/bcp.70586 | PMID 42095574 Get It

Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW). To address this gap, we examined drug metabolites in HIV susceptible cells isolated from blood and rectal tissues of TGW and CGW. Materials and Methods We enrolled 23 TGW, 13 on FHT and 10 CGW. Participants received five directly observed daily PrEP doses: emtricitabine 200 mg with either tenofovir disoproxil fumarate 300 mg (FTC/TDF) or tenofovir alafenamide 25 mg (FTC/TAF). Blood and rectal tissue samples were obtained. Mononuclear and CD4 + cells were isolated and analysed for intracellular triphosphorylated nucleotides (TFVdp and FTCtp) and total nucleotide pools (pTFV and pFTC) using HPLC‐MS/MS. Serum hormone concentrations were quantified via enzyme immunoassay. Results and Conclusion Total nucleotide pools (pTFV and pFTC) correlated with active metabolites (TFVdp and FTCtp) in blood and rectal CD4 + cells ( r 2 > 0.75, p < .001). No significant differences in pTFV or pFTC concentrations were observed between high and low oestradiol groups in either CGW or TGW ( p > .1). No correlation was observed between serum oestradiol concentrations and nucleotide concentrations. TAF resulted in 6.8‐fold higher median pTFV concentrations in blood CD4 + cells ( p < .001) but eightfold lower median pTFV concentrations in rectal CD4 + cells compared to TDF ( p = .008). These findings suggest that neither endogenous hormonal fluctuations in CGW nor exogenous FHT in TGW adversely impact intracellular PrEP pharmacology in key HIV target cells.
Phylogenetic Analysis and Structural Evaluation of Staphylococcus aureus Serine-Aspartate Repeat-Containing Protein D with a Focus on Periprosthetic Joint Infection
Tan, Kemin, O’Connor, Kathleen , Gade, Priyanka, Garcia, Elijah J., Tan, Angela, Nijhawan, Adam K. , Endres, Mike, Kim, Youngchang, Greenwood-Quaintance, Kerryl, Patel, Robin, Joachimiak, A. , O'Connor, Kathleen A, Joachimiak, Andrzej , Zuo, Xiaobing , Gade, Priyanka , Nijhawan, Adam K. , Greenwood‐Quaintance, Kerryl E. , Patel, Robin

Mayo Clinic

No container title available | May 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.01.722179 | PMID 42146440 Get It

ABSTRACT Serine–aspartate repeat-containing protein D (SdrD) is a Staphylococcus aureus cell wall–anchored, calcium-binding adhesin member of the MSCRAMM Sdr subfamily that may contribute to bacterial adhesion and virulence. S. aureus is the most common cause of periprosthetic joint infection (PJI). Population-level distribution and sequence diversity of SdrD among clinical PJI isolates have not been systematically characterized, and the SdrD binding mechanism is still not well understood. To address these gaps, sdrD alleles were queried across 156 newly sequenced PJI isolates and compared to publicly available S. aureus genomes, and nucleotide– and protein-level phylogenies of the sdrCDE locus constructed. The SdrD crystal structure from S. aureus JH1 was determined, with solution small-angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations, and assessment of conformational changes with calcium depletion. Three dominant sdrD subtypes were defined, associating with USA300, JH1, and TCH60; the JH1 sdrD subtype was predominant among PJI isolates. Structural studies showed that the conformation of individual domains and interdomain organization of the multidomain SdrD have limited flexibility in solution, and that the calcium-binding B domain retains its core fold under conditions of calcium depletion. Together, the findings presented support functional diversification among Sdr family members in mediating host attachment and inform a re-evaluation of the ligand-binding mechanism previously proposed for SdrD. AUTHOR SUMMARY Staphylococcus aureus is the leading cause of infections that develop around joint implants (periprosthetic joint infection, PJI). This bacterium has a large arsenal of surface proteins that allow it to stick to human tissues and implanted devices. This work focused on one such protein, SdrD, which has been linked to implant-associated infections but the structure and diversity of which among patients with PJI had not been well characterized. The genetic sequences of SdrD were analyzed across thousands of bacterial genomes, including those from patients with PJI. Distinct genetic variants of the protein were found, one of which was particularly common with PJI. The three-dimensional structure of SdrD was determined at atomic resolution and solution small-angle X-ray scattering (SAXS) and molecular dynamics used to study how it moves and responds to changes in its environment. Contrary to what was previously described, SdrD was shown to be relatively rigid. These findings change how SdrD’s mechanism of action should be considered, potentially informing design strategies to block bacterial attachment before infection takes hold.
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
Duffy, Joseph , Haupt, Benedikt , Pogue, Jacob R, Thakur, Aditi , Cota, Manuel Fierro, Zannikou, Markella, Misener, Sol , Miska, Jason , Horbinski, Craig, Simberg, Dmitri , Lesniak, Maciej S, James, C. David , Balyasnikova, Irina V. , Balyasnikova, Irina V , Martín‐Regalado, Ángela , Thakur, Aditi, Ζαννίκου, Μαρκέλλα , Krymskaya, Vera P. , McCortney, Kathleen , Horbinski, Craig , Lesniak, Maciej S. , Stupp, Roger

Mayo Clinic

Advanced Science | April 30, 2026 | Volume: 13 | Issue: 35 | Pages: No page available

10.1002/advs.202522391 | PMID 42057694 Get It

ABSTRACT Bispecific T cell engagers (BTEs) induce MHC‐independent cytotoxicity by bridging T cells to tumor cells via binding a T cell–activating receptor and a tumor‐associated antigen. BTEs have proven effective in hematologic malignancies and some solid tumors, yet their potential in glioblastoma (GBM) is largely unexplored. We developed a fully humanized BTE (hBTE) targeting interleukin‐13 receptor alpha 2 (IL13RA2), a tumor‐associated antigen widely expressed in GBM and associated with poor prognosis. In vitro, hBTE activated T cells and induced antigen‐dependent cytokine release and cytotoxicity against IL13RA2‐positive GBM cells. In vivo, hBTE showed robust target‐specific activity and markedly prolonged survival in primary and recurrent GBM xenograft models, without detectable off‐target local or systemic toxicity. Beyond GBM, hBTE also exhibited antitumor activity in IL13RA2‐expressing solid tumors, demonstrating selective tumor accumulation and therapeutic efficacy in models of breast cancer brain metastases and extracranial lung cancer. This work highlights the therapeutic potential of BTEs in IL13RA2‐expressing tumors and establishes a strong preclinical rationale for advancing hBTE therapy toward clinical translation in GBM and other tumors.
Update from the Long-Term Follow-Up Phase of ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Adults and Children with Neurofibromatosis Type 1-Associated Symptomatic Plexiform Neurofibroma
Hirbe, A., Shuhaiber, H., Viskochil, D., Sidhu, A., Meade, J., Weintraub, L., Langseth, A., Weber, M., Lokku, A., Hajjar, F., Antony, R., Schiff, D., Raslan, A., Nevel, K., Babovic-Vuksanovic, D., Gershon, T., Hirbe, Angela C. , Shuhaiber, Hans, Viskochil, David , Sidhu, A., Langseth, Abraham J. , Lokku, Armend, Hajjar, Fouad, Babovic‐Vuksanovic, Dusica , Gershon, Timothy R.

Mayo Clinic

Neuropediatrics | April 27, 2026 | Volume: 57 | Issue: No issue available | Pages: No page available

10.1055/s-0046-1822861 Get It

Addressing Skin Adverse Events during Mirdametinib Treatment in Patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Guidance from Experts on the Management of MEK Inhibitor-Associated Skin AEs
Hirbe, A., Anadkat, M., Boull, C., Nickerson, M., Weber, M., Babovic-Vuksanovic, D., Gershon, T., Hirbe, Angela C. , Anadkat, Milan J. , Boull, Christina , Babovic‐Vuksanovic, Dusica , Gershon, Timothy R.

Mayo Clinic

Neuropediatrics | April 27, 2026 | Volume: 57 | Issue: No issue available | Pages: No page available

10.1055/s-0046-1822860 Get It

Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
Eliashiv, Dawn , Rao, Vikram R. , Jobst, Barbara C. , Szaflarski, Jerzy P. , Rolston, John D., Kaye, Lesley , Bullinger, Katie L. , Dugan, Patricia , Burdette, David E. , Peters, Angela , Sheikh, Atif, Haas, Kevin F., Mnatsakanyan, Lilit , Bensalem‐Owen, Meriem, Study, for the RNS System PAS, Doherty, Michael J., Razavi, Babak, Fisher, Tiffany , Modur, Pradeep N., Constantino, Tawnya, Salanova, Vicenta , Taraschenko, Olga , Rivera‐Cruz, Angélica , Balabanov, Antoaneta, Aboumatar, Sami, Fried, Itzhak , Drees, Cornelia , Shin, Hae Won, Jaisani, Zeenat , Maciver, Stephanie , Patra, Sanjay , Chang, Edward F. , Gwinn, Ryder, Stoub, Travis , Crabtree, Tami , Seale, Cairn G. , McFadden, Sharon C. , Norman, Jacob F. , Johnson, Lise, Elisevich, Kort, Peng, Emory, Mazumder, Rajashi, Jennings, Tara, Esparza, Melissa Johnston, Harid, Nitish, Farooque, Pue , Hirsch, Lawrence, Gerrard, Jason, Wabulya, Angela , Riley, Kristen, Pati, Sandipan, Johnson, Jessica, Kirchoffer, Kaitlyn, Bamps, Yvan , Rolston, John D. , Rolston, John D , Kaye, Lesley C , Ganguly, Taneeta Mindy , Bullinger, Katie , Dugan, Patricia C , Burdette, David E , Peters, Angela Y , Sheikh, Atif , Haas, Kevin F , Nair, Dileep R , Mnatsakanyan, Lilit , Quraishi, Imran H , Bensalem-Owen, Meriem K , Doherty, Michael J , Razavi, Babak , Fisher, Tiffany L. , Skidmore, Christopher , Modur, Pradeep N , Constantino, Tawnya M , Cole, Andrew J , Taraschenko, Olga , Rivera-Cruz, Angelica , Wheless, James W , Tandon, Nitin , Balabanov, Antoaneta , Aboumatar, Sami , Fried, Itzhak , Drees, Cornelia , Shin, Hae Won , Jaisani, Zeenat , MacIver, Stephanie E , Patra, Sanjay E , Chang, Edward F , Willie, Jon T , Gwinn, Ryder , Stoub, Travis , Stern, John M , Crabtree, Tami , McFadden, Sharon C , Norman, Jacob F , Johnson, Lise , Morrell, Martha J , Jobst, Barbara , Rao, Vikram R , Ganguly, Taneeta M. , Nair, Dileep , Skidmore, Christopher , Cole, Andrew J. , Wheless, James W. , Tandon, Nitin , Gwinn, Ryder P. , Stern, John M. , Morrell, Martha J. , Pellinen, Jacob , Herlopian, Aline , Sivaraju, Adithya , Damisah, Eyiyemisi C. , Gerrard, Jason L. , Bentley, J. Nicole , Pati, Sandipan Bankim Behari

Mayo Clinic

Neurology | April 24, 2026 | Volume: 106 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000214875 | PMID 42030518 Get It

A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Lim, Kenneth J C , Greipp, Patricia T. , Kelemen, Katalin, Jevremovic, Dragan, Buadi, Francis K. , Dingli, David, Hayman, Suzanne R. , Kapoor, Prashant , Fonder, Amie , Hobbs, Miriam A, Hwa, Y., Warsame, Rahma , Kourelis, Taxiarchis , Abdallah, Nadine, Zanwar, Saurabh , Lin, Yi, Go, Ronald S., Ailawadhi, Sikander, Cooke, Rachel E. , Zordan, Adrian Carl, Ninkovic, Slavisa , Best, Sharene, Alatorre, Gabriela, Wiedmeier-Nutor, Julia Erin, Einsele, H, Kyle, Robert A, Gertz, MA, Kumar, Shaji , Rajkumar, S Vincent, Fonseca, Rafael, Gonsalves, Wilson I, Yadav, Udit , Rees, Matthew James , Greipp, Patricia T , Dispenzieri, Angela , Baughn, Linda, Buadi, Francis K , Muchtar, E , Leung, Nelson , Fonder, Amie , Hwa, Yi Lisa, Warsame, Rahma , Kourelis, Taxiarchis , Cook, Joselle M , Binder, Moritz , Abdallah, Nadine H , Zanwar, Saurabh S , Siddiqui, Mustaqeem A , Parrondo, Ricardo D , Ailawadi, Sikander, Roy, Vivek , Cooke, Rachel , Best, Sharene H, Alatorre, Gabriela A, Kortüm, Martin , Chhabra, Saurabh , Bergsagel, P. Leif , Gertz, Morie A , Kumar, Shaji K , Fonseca, Rafael , Yadav, Udit , Lim, Kenneth J C , Steinhardt, Maximilian , Rees, Matthew J. , Dispenzieri, Angela , Jevremović, Dragan , Baughn, Linda B. , Dingli, David , Muchtar, Eli , Leung, Nelson , Hobbs, Miriam, Cook, Joselle , Binder, Moritz , Abdallah, Nadine , Go, Ronald S. , Siddiqui, Mustaqeem , Ailawadhi, Sikander , Roy, Vivek , Dun, Karen A. , Zordan, Adrian, Kortüm, K. Martin , Einsele, Hermann , Chhabra, Saurabh , Bergsagel, P. Leif , Kyle, R., Gertz, Morie A. , Rajkumar, S. Vincent , Fonseca, Rafaël , Gonsalves, Wilson I.

Mayo Clinic

Blood Advances | April 22, 2026 | Volume: 10 | Issue: 12 | Pages: 4286-4295

10.1182/bloodadvances.2025019136 | PMID 42018661 Get It

Abstract Solitary bone plasmacytoma (SBP) and SBP with minimal marrow involvement (SBPmm) are treated similarly with definitive radiation therapy (RT) followed by observation. However, differences in the natural disease course after RT between the two, are not well described. We performed a multicenter study assessing outcomes after RT in 141 patients with SBP and 102 with SBPmm diagnosed between January 2010 and December 2024. About 92% of patients with SBPmm progressed to multiple myeloma (MM) vs 76% of those with SBP (P = .01). Among patients with SBP, 21% progressed with a second solitary bone lesion vs 4% with SBPmm (P&lt; .01). Patients with longer time to progression (TTP) after initial RT could achieve durable responses with RT to a second solitary plasmacytoma in the absence of other myeloma-defining events (MDE). Multifocal lytic bone lesions were the most common MDE, occurring in 89% and 81% of patients with SBPmm and SBP, respectively. Patients with SBPmm had a median TTP of 15 months (95% confidence interval [CI], 14-21) compared to 43 months (95% CI, 34-55) for those with SBP (P&lt; .0001); 67% with SBPmm progressed within 2 years of diagnosis. Del(17p) and 1q+ (gain or amplification) were associated with shorter TTP to MM in SBPmm, with 2-year progression rates of 100% and 82%, respectively. We report significant differences in risk and modes of progression between SBP and SBPmm. Patients with SBPmm are at particularly high risk for early progression to MM, with most developing bone disease as the MDE. These findings support prospective studies incorporating frontline systemic therapy for SBPmm.
Association of Meeting Physical Activity Guidelines With Psychosocial and Health Outcomes in Spinal Cord Injury
Monden, Kimberley R. , Philippus, Angela Hanks, Pai, Nidhi, Shogren, Carrie, Cui, Erjia, Kowalski, Jesse L. , Welch, Abby, Herrmann, Amanda A. , Hanson, Leah R. , Srivastava, Shraddha , DeRasmi, Amanda, Felix, Elizabeth R. , Groah, Suzanne, Guemez, Ana Valeria Aguirre, Martinez, Katherine, Morse, Leslie R. , Worobey, Lynn A. , Philippus, Angela , Reeves, Ronald K. , Pai, Nidhi , Anderson, Kim D. , Groah, Suzanne L. , Aguirre-Güemez, Ana Valeria

Mayo Clinic

Topics in Spinal Cord Injury Rehabilitation | April 22, 2026 | Volume: 32 | Issue: Supplement1 | Pages: 103-117

10.46292/sci25-00120 | PMID 42028360 Get It

Background: Physical inactivity is highly prevalent among individuals with spinal cord injury (SCI), contributing to secondary health conditions and reduced quality of life (QOL). Objectives: To examine the independent associations between adherence to SCI cardiorespiratory fitness guidelines and health and psychosocial outcomes, while controlling for relevant covariates. Method: We conducted a multisite, cross-sectional study of adults with traumatic SCI stratified by self-reported leisure-time physical activity: no activity (28%), some activity (41%), and met guidelines (26%). Multivariable regression models analyzed associations between physical activity (PA) group and outcomes of hospitalization, self-perceived health, resilience (SCI-QOL Resilience), pain, depression (PHQ-8), QOL (SWLS), and social integration (CHART-SF). Results: The study included 361 participants (no activity, 28%; some activity, 41%; met guidelines, 26%). Meeting PA guidelines was associated with better self-perceived health (odds ratio [OR] 2.79, P < .001) and higher resilience (β = 1.78, P = .04) compared to the No Activity group. However, hospitalization risk was unexpectedly higher for both the Some Activity (risk ratio [RR] 1.93, P = .005) and Met Guidelines (RR 1.75, P = .03) groups. After adjusting for covariates, PA was not significantly associated with pain, depression, QOL, or social integration; instead, higher income was consistently associated with better outcomes in these domains. Conclusion: Adherence to SCI exercise guidelines is associated with enhanced self-perceived health and resilience. However, PA alone was not associated with broader psychosocial outcomes in this model, where socioeconomic factors such as income appeared to play a significant explanatory role.